HemoBioTech, Inc.
Overview
HemoBioTech, Inc. is a biotechnology company focused on developing Hemoglobin Based Oxygen Carriers for use as a blood substitute. Its primary aim is to address blood supply shortages and eliminate risks associated with blood transfusions. The company's pioneering work could revolutionize the medical field by providing a safe and effective alternative to human blood.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to HemoBioTech, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this HemoBioTech, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.